• Panels
    • ePlex Panels
      • Respiratory
      • Blood Culture
    • XT-8 Panels
  • Systems
    • ePlex System
      • Software Solutions
      • Patient Safety
    • XT-8 System
  • Company
    • The GenMark Story
      • Management Team
      • Board of Directors
    • Careers
      • Opportunities
    • Investors
    • Newsroom
  • Education
    • Disease State
      • Sepsis
      • Respiratory Infections
      • Genetic Conditions
      • Hepatitis
      • GI Infections
    • Technology
    • Resources
  • Support
    • Contact Us
    • FAQs
    • Safety Data Sheets (SDS)
    • Your Long-Term Partner
CONTACT US | CUSTOMER RESOURCE CENTER
GenMark
  • Panels
    • ePlex Panels
      • Respiratory
      • Blood Culture
    • XT-8 Panels
  • Systems
    • ePlex System
      • Software Solutions
      • Patient Safety
    • XT-8 System
  • Company
    • The GenMark Story
      • Management Team
      • Board of Directors
    • Careers
      • Opportunities
    • Investors
    • Newsroom
  • Education
    • Disease State
      • Sepsis
      • Respiratory Infections
      • Genetic Conditions
      • Hepatitis
      • GI Infections
    • Technology
    • Resources
  • Support
    • Contact Us
    • FAQs
    • Safety Data Sheets (SDS)
    • Your Long-Term Partner

 

Respiratory Pathogen Panel (RP)1 and NEW Respiratory Pathogen Panel 2 (RP2)2

GenMark’s Respiratory Pathogen Panels identify the most common viral and bacterial organisms associated with upper respiratory infection, including SARS-CoV-2, the virus that causes COVID-19 (on the RP2 Panel).

 

VIEW BROCHURE

 

 

 

 

 

 

 

Co-circulation of Pathogens During Respiratory Illness Season

During the annual respiratory illness season when infections tend to peak (October through March in the northern hemisphere and April through September in the southern hemisphere), influenza is often the first virus people think of.3 In the US, the CDC estimates that 8% of the population will be sick from the flu each year, varying from 3-11% depending on the year.4 Some viruses, such as Respiratory Syncytial Virus (RSV) and metapneumovirus, are also more prevalent at certain times of the year, while others, like adenovirus and rhinovirus, are common year-round. No seasonality for SARS-CoV-2 has been identified yet and infections are expected to remain elevated during respiratory illness season.

 

 

 

Comprehensive Pathogen Coverage Impacts Patient Care

The ePlex RP/RP2 Panels identify and detect more than 20 of the most common respiratory viruses and bacteria causing respiratory illness in less than 2 hours, allowing doctors to make informed patient care decisions faster. Rapid diagnosis is important for people who are more likely to become seriously ill from complications or require hospitalization, such as young children, adults 65 and older, pregnant women and those with compromised immune systems.

 

The emergence of SARS-CoV-2 in late 2019  sparked a global pandemic, with cases and deaths continuing to rise. The high mortality associated with COVID-19 and the need for rapid isolation to reduce spread and prompt initiation of treatment makes it more critical than ever to quickly identify the cause of respiratory infections.

 

VIEW INFOGRAPHIC

 

 

 

 

 

RP Panel Targets

RP2 Panel Targets

Adenovirus

Adenovirus

Coronavirus (229E, HKU1, NL63, OC43)

Coronavirus (229E, HKU1, NL63, OC43)

Human Metapneumovirus

SARS-CoV-2

Human Rhinovirus/Enterovirus

Human Metapneumovirus

Influenza A

Human Rhinovirus/Enterovirus

Influenza A H1

Influenza A

Influenza A H1-2009

Influenza A H1

Influenza A H3

Influenza A H1-2009

Influenza B

Influenza A H3

Parainfluenza 1

Influenza B

Parainfluenza 2

Parainfluenza 1

Parainfluenza 3

Parainfluenza 2

Parainfluenza 4

Parainfluenza 3

Respiratory Syncytial Virus A

Parainfluenza 4

Respiratory Syncytial Virus B

Respiratory Syncytial Virus A

Chlamydia pneumoniae

Respiratory Syncytial Virus B

Mycoplasma pneumoniae

Chlamydia pneumoniae

Mycoplasma pneumoniae

 

 

 

 

[P]

The True Sample-to-Answer Solution® 

To learn more about the Respiratory Pathogen (RP) Panels or to schedule a demonstration, contact us at 1.800.373.6767 or email us.

 

SCHEDULE A DEMONSTRATION VIA EMAIL

 

 

 

 

 

1. For in vitro diagnostic Use.
2. For use under the Emergency use Authorization (EUA) only. For in vitro diagnostic use.
3. World Health Organization. How can I avoid getting the flu? https://www.who.int/news-room/q-a-detail/how-can-i-avoid-getting-the-flu (Last updated January 2020).
4. Centers for Disease Control. Key Facts About Influenza. https://www.cdc.gov/flu/about/keyfacts.htm (accessed December 2020).

GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad, CA 92008

 

© Copyright 2021 GenMark Diagnostics, Inc.
All rights reserved.

 

info@genmarkdx.com
P: +1 760-448-4300
F: +1 760-448-4301

 

Legal | Privacy Policy

 

 

Popup Button